International perspectives on the implementation of reproductive carrier screening

Martin B Delatycki, Fowzan Alkuraya, Alison Archibald, Carlo Castellani, Martina Cornel, Wayne W Grody, Lidewij Henneman, Adonis S Ioannides, Edwin Kirk, Nigel Laing, Anneke Lucassen, John Massie, Juliette Schuurmans, Meow-Keong Thong, Irene van Langen, Joël Zlotogora

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Reproductive carrier screening started in some countries in the 1970s for hemoglobinopathies and Tay-Sachs disease. Cystic fibrosis carrier screening became possible in the late 1980s and with technical advances, screening of an ever increasing number of genes has become possible. The goal of carrier screening is to inform people about their risk of having children with autosomal recessive and X-linked recessive disorders, to allow for informed decision making about reproductive options. The consequence may be a decrease in the birth prevalence of these conditions, which has occurred in several countries for some conditions. Different programs target different groups (high school, premarital, couples before conception, couples attending fertility clinics, and pregnant women) as does the governance structure (public health initiative and user pays). Ancestry-based offers of screening are being replaced by expanded carrier screening panels with multiple genes that is independent of ancestry. This review describes screening in Australia, Cyprus, Israel, Italy, Malaysia, the Netherlands, Saudi Arabia, the United Kingdom, and the United States. It provides an insight into the enormous variability in how reproductive carrier screening is offered across the globe. This largely relates to geographical variation in carrier frequencies of genetic conditions and local health care, financial, cultural, and religious factors.

Original languageEnglish
JournalPrenatal Diagnosis
Early online date29 Nov 2019
DOIs
Publication statusE-pub ahead of print - 29 Nov 2019

Cite this

Delatycki, M. B., Alkuraya, F., Archibald, A., Castellani, C., Cornel, M., Grody, W. W., ... Zlotogora, J. (2019). International perspectives on the implementation of reproductive carrier screening. Prenatal Diagnosis. https://doi.org/10.1002/pd.5611
Delatycki, Martin B ; Alkuraya, Fowzan ; Archibald, Alison ; Castellani, Carlo ; Cornel, Martina ; Grody, Wayne W ; Henneman, Lidewij ; Ioannides, Adonis S ; Kirk, Edwin ; Laing, Nigel ; Lucassen, Anneke ; Massie, John ; Schuurmans, Juliette ; Thong, Meow-Keong ; van Langen, Irene ; Zlotogora, Joël. / International perspectives on the implementation of reproductive carrier screening. In: Prenatal Diagnosis. 2019.
@article{a1c031f363344e3d91046cce14f4bc5a,
title = "International perspectives on the implementation of reproductive carrier screening",
abstract = "Reproductive carrier screening started in some countries in the 1970s for hemoglobinopathies and Tay-Sachs disease. Cystic fibrosis carrier screening became possible in the late 1980s and with technical advances, screening of an ever increasing number of genes has become possible. The goal of carrier screening is to inform people about their risk of having children with autosomal recessive and X-linked recessive disorders, to allow for informed decision making about reproductive options. The consequence may be a decrease in the birth prevalence of these conditions, which has occurred in several countries for some conditions. Different programs target different groups (high school, premarital, couples before conception, couples attending fertility clinics, and pregnant women) as does the governance structure (public health initiative and user pays). Ancestry-based offers of screening are being replaced by expanded carrier screening panels with multiple genes that is independent of ancestry. This review describes screening in Australia, Cyprus, Israel, Italy, Malaysia, the Netherlands, Saudi Arabia, the United Kingdom, and the United States. It provides an insight into the enormous variability in how reproductive carrier screening is offered across the globe. This largely relates to geographical variation in carrier frequencies of genetic conditions and local health care, financial, cultural, and religious factors.",
author = "Delatycki, {Martin B} and Fowzan Alkuraya and Alison Archibald and Carlo Castellani and Martina Cornel and Grody, {Wayne W} and Lidewij Henneman and Ioannides, {Adonis S} and Edwin Kirk and Nigel Laing and Anneke Lucassen and John Massie and Juliette Schuurmans and Meow-Keong Thong and {van Langen}, Irene and Jo{\"e}l Zlotogora",
note = "{\circledC} 2019 John Wiley & Sons, Ltd.",
year = "2019",
month = "11",
day = "29",
doi = "10.1002/pd.5611",
language = "English",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",

}

Delatycki, MB, Alkuraya, F, Archibald, A, Castellani, C, Cornel, M, Grody, WW, Henneman, L, Ioannides, AS, Kirk, E, Laing, N, Lucassen, A, Massie, J, Schuurmans, J, Thong, M-K, van Langen, I & Zlotogora, J 2019, 'International perspectives on the implementation of reproductive carrier screening' Prenatal Diagnosis. https://doi.org/10.1002/pd.5611

International perspectives on the implementation of reproductive carrier screening. / Delatycki, Martin B; Alkuraya, Fowzan; Archibald, Alison; Castellani, Carlo; Cornel, Martina; Grody, Wayne W; Henneman, Lidewij; Ioannides, Adonis S; Kirk, Edwin; Laing, Nigel; Lucassen, Anneke; Massie, John; Schuurmans, Juliette; Thong, Meow-Keong; van Langen, Irene; Zlotogora, Joël.

In: Prenatal Diagnosis, 29.11.2019.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - International perspectives on the implementation of reproductive carrier screening

AU - Delatycki, Martin B

AU - Alkuraya, Fowzan

AU - Archibald, Alison

AU - Castellani, Carlo

AU - Cornel, Martina

AU - Grody, Wayne W

AU - Henneman, Lidewij

AU - Ioannides, Adonis S

AU - Kirk, Edwin

AU - Laing, Nigel

AU - Lucassen, Anneke

AU - Massie, John

AU - Schuurmans, Juliette

AU - Thong, Meow-Keong

AU - van Langen, Irene

AU - Zlotogora, Joël

N1 - © 2019 John Wiley & Sons, Ltd.

PY - 2019/11/29

Y1 - 2019/11/29

N2 - Reproductive carrier screening started in some countries in the 1970s for hemoglobinopathies and Tay-Sachs disease. Cystic fibrosis carrier screening became possible in the late 1980s and with technical advances, screening of an ever increasing number of genes has become possible. The goal of carrier screening is to inform people about their risk of having children with autosomal recessive and X-linked recessive disorders, to allow for informed decision making about reproductive options. The consequence may be a decrease in the birth prevalence of these conditions, which has occurred in several countries for some conditions. Different programs target different groups (high school, premarital, couples before conception, couples attending fertility clinics, and pregnant women) as does the governance structure (public health initiative and user pays). Ancestry-based offers of screening are being replaced by expanded carrier screening panels with multiple genes that is independent of ancestry. This review describes screening in Australia, Cyprus, Israel, Italy, Malaysia, the Netherlands, Saudi Arabia, the United Kingdom, and the United States. It provides an insight into the enormous variability in how reproductive carrier screening is offered across the globe. This largely relates to geographical variation in carrier frequencies of genetic conditions and local health care, financial, cultural, and religious factors.

AB - Reproductive carrier screening started in some countries in the 1970s for hemoglobinopathies and Tay-Sachs disease. Cystic fibrosis carrier screening became possible in the late 1980s and with technical advances, screening of an ever increasing number of genes has become possible. The goal of carrier screening is to inform people about their risk of having children with autosomal recessive and X-linked recessive disorders, to allow for informed decision making about reproductive options. The consequence may be a decrease in the birth prevalence of these conditions, which has occurred in several countries for some conditions. Different programs target different groups (high school, premarital, couples before conception, couples attending fertility clinics, and pregnant women) as does the governance structure (public health initiative and user pays). Ancestry-based offers of screening are being replaced by expanded carrier screening panels with multiple genes that is independent of ancestry. This review describes screening in Australia, Cyprus, Israel, Italy, Malaysia, the Netherlands, Saudi Arabia, the United Kingdom, and the United States. It provides an insight into the enormous variability in how reproductive carrier screening is offered across the globe. This largely relates to geographical variation in carrier frequencies of genetic conditions and local health care, financial, cultural, and religious factors.

U2 - 10.1002/pd.5611

DO - 10.1002/pd.5611

M3 - Review article

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

ER -